TABLE 4.
Genes in eECs differentially induced by rSP and the MV fraction from infected individualsa
| rSP from HIV-infected individuals vs rSP from uninfected individuals |
MVs from HIV-infected individuals vs MVs from uninfected individuals |
||||
|---|---|---|---|---|---|
| Gene regulation and gene | P value | Fold change in expression | Gene regulation and gene | P value | Fold change in expression |
| Upregulated by rSP from HIV-infected individuals | Upregulated by MV from HIV-infected individuals | ||||
| HIF1A-AS2 | <0.001 | 3.48 | HIST1H3E | 0.02 | 2.45 |
| VGF | 0.02 | 2.20 | FAM229A | 0.04 | 1.80 |
| FAM229A | 0.03 | 1.52 | HIST2H2AC | 0.04 | 1.66 |
| RPL21P44 | 0.03 | 1.62 | |||
| RPS15AP10 | 0.01 | 1.59 | |||
| EXOC3-AS1 | 0.02 | 1.56 | |||
| Downregulated by rSP from HIV-infected individuals | Downregulated by MV from HIV-infected individuals | ||||
| KMT2 | 0.04 | 1.92 | ZNF43 | 0.04 | 7.82 |
| AOC2 | 0.04 | 1.86 | MT1G | 0.02 | 3.75 |
| SPEN | 0.04 | 1.86 | MT1H | <0.001 | 2.79 |
| AHNAK | 0.05 | 1.72 | CCDC89 | 0.04 | 1.81 |
| CRIPAK | 0.05 | 1.65 | SST | 0.01 | 1.54 |
| LOC728752 | <0.001 | 1.63 | |||
| RSAD2 | 0.02 | 1.60 | |||
| OAS2 | <0.001 | 1.59 | |||
| MSMP | 0.02 | 1.54 | |||
| OAS3 | <0.001 | 1.54 | |||
| EIF2AK2 | 0.03 | 1.54 | |||
| SAMD9 | 0.02 | 1.51 | |||
Genes with a ≥1.5-fold change in expression between treatment groups with a P value of <0.05.